valerates has been researched along with o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate in 2 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate) | Trials (o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate) | Recent Studies (post-2010) (o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 190 | 1 | 74 |
Protein | Taxonomy | valerates (IC50) | o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate (IC50) |
---|---|---|---|
Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.46 | |
Acetylcholinesterase | Mus musculus (house mouse) | 0.063 | |
Cannabinoid receptor 1 | Mus musculus (house mouse) | 0.003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borazjani, A; Crow, JA; Potter, PM; Ross, MK | 1 |
Fink, JK; Hein, ND; Rainier, SR; Richardson, RJ; Stuckey, JA | 1 |
2 other study(ies) available for valerates and o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate
Article | Year |
---|---|
Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases.
Topics: Animals; Benzyl Alcohols; Blotting, Western; Carboxylesterase; Carboxylic Ester Hydrolases; Chlorpyrifos; Electrophoresis, Polyacrylamide Gel; Humans; Hydrolysis; Intestines; Kinetics; Lipase; Liver; Microsomes, Liver; Molecular Structure; Nitrobenzoates; Pancreas; Pyrethrins; Rats; Thiolester Hydrolases; Umbelliferones; Valerates | 2007 |
Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.
Topics: Carboxylic Ester Hydrolases; Catalytic Domain; Chlorpyrifos; Enzyme Inhibitors; Humans; Hydrolysis; Isoflurophate; Kinetics; Motor Neuron Disease; Mutagenesis, Site-Directed; Mutation; Recombinant Proteins; Spastic Paraplegia, Hereditary; Substrate Specificity; Valerates | 2010 |